vs
Side-by-side financial comparison of Presurance Holdings, Inc. (PRHI) and Precipio, Inc. (PRPO). Click either name above to swap in a different company.
Precipio, Inc. is the larger business by last-quarter revenue ($6.8M vs $5.7M, roughly 1.2× Presurance Holdings, Inc.). Precipio, Inc. runs the higher net margin — 7.7% vs -369.2%, a 376.9% gap on every dollar of revenue. On growth, Precipio, Inc. posted the faster year-over-year revenue change (28.4% vs -61.4%). Over the past eight quarters, Precipio, Inc.'s revenue compounded faster (40.0% CAGR vs -44.7%).
Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.
PRHI vs PRPO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.7M | $6.8M |
| Net Profit | $-17.0M | $526.0K |
| Gross Margin | — | 45.9% |
| Operating Margin | -322.7% | 7.9% |
| Net Margin | -369.2% | 7.7% |
| Revenue YoY | -61.4% | 28.4% |
| Net Profit YoY | 32.9% | 244.1% |
| EPS (diluted) | $-1.40 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.7M | $6.8M | ||
| Q3 25 | $6.8M | $6.9M | ||
| Q2 25 | $16.1M | $5.6M | ||
| Q1 25 | $15.9M | $4.9M | ||
| Q4 24 | $14.7M | $5.3M | ||
| Q3 24 | $16.0M | $5.3M | ||
| Q2 24 | $17.9M | $4.5M | ||
| Q1 24 | $18.6M | $3.5M |
| Q4 25 | $-17.0M | $526.0K | ||
| Q3 25 | $-4.0M | $-79.0K | ||
| Q2 25 | $2.1M | $74.0K | ||
| Q1 25 | $522.0K | $-884.0K | ||
| Q4 24 | $-25.4M | $-365.0K | ||
| Q3 24 | $52.8M | $-626.0K | ||
| Q2 24 | $-4.0M | $-1.2M | ||
| Q1 24 | $74.0K | $-2.1M |
| Q4 25 | — | 45.9% | ||
| Q3 25 | — | 43.6% | ||
| Q2 25 | — | 43.2% | ||
| Q1 25 | — | 43.6% | ||
| Q4 24 | — | 49.8% | ||
| Q3 24 | — | 43.1% | ||
| Q2 24 | — | 38.1% | ||
| Q1 24 | — | 26.5% |
| Q4 25 | -322.7% | 7.9% | ||
| Q3 25 | -42.7% | -0.9% | ||
| Q2 25 | -22.6% | -14.6% | ||
| Q1 25 | -27.9% | -17.5% | ||
| Q4 24 | -177.1% | -6.3% | ||
| Q3 24 | -45.8% | -11.3% | ||
| Q2 24 | -24.3% | -26.8% | ||
| Q1 24 | 2.7% | -59.6% |
| Q4 25 | -369.2% | 7.7% | ||
| Q3 25 | -58.2% | -1.1% | ||
| Q2 25 | 12.7% | 1.3% | ||
| Q1 25 | 3.3% | -18.0% | ||
| Q4 24 | -172.4% | -6.9% | ||
| Q3 24 | 329.6% | -11.9% | ||
| Q2 24 | -22.1% | -27.1% | ||
| Q1 24 | 0.4% | -59.8% |
| Q4 25 | $-1.40 | $0.36 | ||
| Q3 25 | $-0.32 | $-0.05 | ||
| Q2 25 | $0.17 | $0.05 | ||
| Q1 25 | $0.04 | $-0.59 | ||
| Q4 24 | $-2.08 | $-0.22 | ||
| Q3 24 | $4.32 | $-0.42 | ||
| Q2 24 | $-0.32 | $-0.83 | ||
| Q1 24 | $0.01 | $-1.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.1M | $2.7M |
| Total DebtLower is stronger | $12.2M | $83.0K |
| Stockholders' EquityBook value | $9.0M | $14.6M |
| Total Assets | $239.3M | $21.3M |
| Debt / EquityLower = less leverage | 1.36× | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.1M | $2.7M | ||
| Q3 25 | $62.3M | $2.3M | ||
| Q2 25 | $58.3M | $1.1M | ||
| Q1 25 | $52.3M | $1.0M | ||
| Q4 24 | $48.8M | $1.4M | ||
| Q3 24 | $53.6M | $1.1M | ||
| Q2 24 | $33.0M | $1.3M | ||
| Q1 24 | $41.0M | $776.0K |
| Q4 25 | $12.2M | $83.0K | ||
| Q3 25 | $12.1M | — | ||
| Q2 25 | $12.1M | — | ||
| Q1 25 | $12.0M | — | ||
| Q4 24 | $11.9M | $383.0K | ||
| Q3 24 | $16.5M | — | ||
| Q2 24 | $24.8M | — | ||
| Q1 24 | $24.9M | — |
| Q4 25 | $9.0M | $14.6M | ||
| Q3 25 | $25.3M | $13.7M | ||
| Q2 25 | $28.2M | $12.3M | ||
| Q1 25 | $25.6M | $11.7M | ||
| Q4 24 | $21.5M | $12.1M | ||
| Q3 24 | $49.1M | $11.9M | ||
| Q2 24 | $-1.2M | $12.1M | ||
| Q1 24 | $2.6M | $12.8M |
| Q4 25 | $239.3M | $21.3M | ||
| Q3 25 | $285.0M | $21.2M | ||
| Q2 25 | $283.3M | $18.8M | ||
| Q1 25 | $277.1M | $17.8M | ||
| Q4 24 | $281.7M | $17.0M | ||
| Q3 24 | $299.9M | $17.0M | ||
| Q2 24 | $292.9M | $17.3M | ||
| Q1 24 | $301.1M | $16.6M |
| Q4 25 | 1.36× | 0.01× | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 0.55× | 0.03× | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 9.75× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-43.9M | $366.0K |
| Free Cash FlowOCF − Capex | — | $291.0K |
| FCF MarginFCF / Revenue | — | 4.3% |
| Capex IntensityCapex / Revenue | — | 1.1% |
| Cash ConversionOCF / Net Profit | — | 0.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $359.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-43.9M | $366.0K | ||
| Q3 25 | $-681.0K | $10.0K | ||
| Q2 25 | $-2.8M | $353.0K | ||
| Q1 25 | $-15.3M | $-44.0K | ||
| Q4 24 | $-32.7M | $565.0K | ||
| Q3 24 | $-10.7M | $41.0K | ||
| Q2 24 | $-10.1M | $500.0K | ||
| Q1 24 | $8.2M | $-667.0K |
| Q4 25 | — | $291.0K | ||
| Q3 25 | — | $-44.0K | ||
| Q2 25 | — | $294.0K | ||
| Q1 25 | — | $-182.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-68.0K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 4.3% | ||
| Q3 25 | — | -0.6% | ||
| Q2 25 | — | 5.2% | ||
| Q1 25 | — | -3.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.70× | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.34× | 4.77× | ||
| Q1 25 | -29.23× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.20× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 110.47× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
